Specificity protein (Sp) transcription factors (Sp1/Sp3/Sp4) are often overexpressed in colon cancer, pancreatic cancer, bladder cancer, breast cancer, prostate cancer, and many other cancers [8–12]. This evidence concerns the gene SP3 and prostate carcinoma.